Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Head lice treatment comparison of NeutraLice Lotion, NeutraLice Advance, and Banlice Mousse
ACTRN12610000179033Phase 4Completed
- Sponsor
- Key Pharmaceuticals Ltd
- Start
- Apr 2009
- Modality
- Small Molecules, Transdermal Patches → Device-based Delivery → Drug Delivery Systems, Hydrogel Systems → Drug Delivery Systems
- Countries
- 1
01
Overview
Phase 4, open-label trial of neutralice advance and pyrethrins + piperonyl butoxide in pediculosis capitis (3 arms), sponsored by Key Pharmaceuticals Ltd. Primary endpoint: Louse-free rate in the intention-to-treat population by wet combing. Started Apr 2009; status: completed.
02
Drugs
neutralice advancepyrethrins + piperonyl butoxide
03
Conditions
pediculosis capitis
Beyond the preview
Go deeper on ACTRN12610000179033.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12610000179033.